BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15199482)

  • 1. The role of the tissue factor-thrombin pathway in cardiac ischemia-reperfusion injury.
    Mackman N
    Semin Vasc Med; 2003 May; 3(2):193-8. PubMed ID: 15199482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation.
    Erlich JH; Boyle EM; Labriola J; Kovacich JC; Santucci RA; Fearns C; Morgan EN; Yun W; Luther T; Kojikawa O; Martin TR; Pohlman TH; Verrier ED; Mackman N
    Am J Pathol; 2000 Dec; 157(6):1849-62. PubMed ID: 11106558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
    Zhang JJ; Kelm RJ; Biswas P; Kashgarian M; Madri JA
    J Cell Physiol; 2007 Feb; 210(2):527-37. PubMed ID: 17111362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury.
    Chong AJ; Pohlman TH; Hampton CR; Shimamoto A; Mackman N; Verrier ED
    Ann Thorac Surg; 2003 Feb; 75(2):S649-55. PubMed ID: 12607707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
    Hedner U; Erhardtsen E
    Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation and the pathogenesis of cancer.
    Ruf W; Mueller BM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tissue factor as an antithrombotic strategy.
    Golino P; Cimmino G
    Semin Vasc Med; 2003 May; 3(2):205-14. PubMed ID: 15199484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary bypass.
    Jormalainen M; Vento AE; Lukkarinen H; Kääpä P; Kytö V; Lauronen J; Paavonen T; Suojaranta-Ylinen R; Petäjä J
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):224-31. PubMed ID: 17418736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tissue factor in intra-alveolar fibrin deposition and coagulopathy associated with pneumonic pasteurellosis in cattle.
    Rashid J; Weiss DJ; Bach R; Murtaugh M
    Am J Vet Res; 1997 Jan; 58(1):28-33. PubMed ID: 8989492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
    Palmerini T; Coller BS; Cervi V; Tomasi L; Marzocchi A; Marrozzini C; Leone O; Piccioli M; Branzi A
    J Am Coll Cardiol; 2004 Oct; 44(8):1570-7. PubMed ID: 15489087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for thrombin receptor signaling in endothelial cells during embryonic development.
    Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
    Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in tissue factor and the effects of tissue factor pathway inhibitor on transient focal cerebral ischemia in rats.
    Niiro M; Nagayama T; Yunoue S; Obara S; Hirano H
    Thromb Res; 2008; 122(2):247-55. PubMed ID: 18067952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor and fibrin in tumor angiogenesis.
    Fernandez PM; Patierno SR; Rickles FR
    Semin Thromb Hemost; 2004 Feb; 30(1):31-44. PubMed ID: 15034796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor-dependent coagulation protease signaling in acute lung injury.
    Ruf W; Riewald M
    Crit Care Med; 2003 Apr; 31(4 Suppl):S231-7. PubMed ID: 12682445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tissue factor in hemostasis, thrombosis, and vascular development.
    Mackman N
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1015-22. PubMed ID: 15117736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats.
    Tsuboi H; Naito Y; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Tsukada M; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G678-83. PubMed ID: 17023547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels.
    Westmuckett AD; Lupu C; Goulding DA; Das S; Kakkar VV; Lupu F
    Thromb Haemost; 2000 Nov; 84(5):904-11. PubMed ID: 11127875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis.
    Lauver DA; Booth EA; White AJ; Poradosu E; Lucchesi BR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):794-800. PubMed ID: 15365091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the tissue factor pathway in initiation of coagulation.
    Mann KG; van't Veer C; Cawthern K; Butenas S
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S3-7. PubMed ID: 9819022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA; Seitz I; Busch G; Stein A; Ott I
    Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.